ENSC Ensysce Biosciences Inc
8,335
$0.6368
$0.0432
(6.35%)
| Watchers | 8,335 |
| 52-Wk Low | $0.512 |
| 52-Wk High | $2.64 |
| Market Cap | $4.83M |
| Volume | 66,975.00 |
| 52-Wk High | $2.64 |
| 52-Wk Low | $0.512 |
Ensysce Biosciences, Inc. (NASDAQ:ENSC) Sees Significant Decrease in Short InterestTicker Report • about 2 months ago
Ensysce Biosciences, Inc. (NASDAQ:ENSC - Get Free Report) was the recipient of a large decline in short interest in the month of March. As of March 15th, there was short interest totalling 56,500...
Share to Feed
Related Stocks: NAS:ENSC...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
Corporate Update Call to be Held Thursday, March 21, 2024 at 11:00am ET to Discuss Recent FDA Breakthrough Therapy Designation and Phase 3 Clinical PlansSAN DIEGO, CA / ACCESSWIRE / March 15, 2024...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
SAN DIEGO, CA / ACCESSWIRE / February 27, 2024 / Ensysce Biosciences, Inc. (the 'Company') (NASDAQ:ENSC), a clinical-stage company applying transformative chemistry to improve prescription drug...
~ PF614-MPAR program receives FDA guidance ~SAN DIEGO, CA / ACCESSWIRE / February 21, 2024 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ('Ensysce' or the 'Company'), a clinical-stage company applying...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
Publication Details Positive Results of Clinical Study PF614-102SAN DIEGO, CA / ACCESSWIRE / February 15, 2024 / Ensysce Biosciences, Inc. (NASDAQ:ENSC)(OTC PINK:ENSCW) ('Ensysce' or 'Company'), a...
SAN DIEGO, CA / ACCESSWIRE / February 13, 2024 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) (the 'Company'), a clinical-stage biotech company applying transformative chemistry to improve prescription...